C07K 2319/85
Containing an rna binding domain
Official title: containing an RNA binding domain
C07K2319/85 (Containing an rna binding domain) appears on 134 US grants and 311 published applications in this corpus.
Search patents in C07K- Granted patents
- 134
- Published applications
- 311
- Assignees
- 175
- Inventors
- 600
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 1 | 1 |
| 2011 | 1 | 4 |
| 2012 | 2 | 8 |
| 2013 | 0 | 8 |
| 2014 | 4 | 7 |
| 2015 | 3 | 10 |
| 2016 | 9 | 12 |
| 2017 | 7 | 9 |
| 2018 | 7 | 19 |
| 2019 | 9 | 21 |
| 2020 | 15 | 25 |
| 2021 | 10 | 28 |
| 2022 | 13 | 27 |
| 2023 | 10 | 21 |
| 2024 | 15 | 32 |
| 2025 | 17 | 45 |
| 2026 | 11 | 29 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Fusion protein comprising anti-CD3 single domain antibody, exosomal protein CD63 and RNA binding protein, and uses thereof6 Oct 2026US 12,753,232 B1China Medical University Hospital
- Fusion protein comprising anti-CD3 single domain antibody, exosomal protein CD63 and RNA binding protein, and uses thereof4 Aug 2026US 12,698,330 B1China Medical University Hospital
- Systems, methods, and compositions for targeted nucleic acid editing16 Jun 2026US 12,655,403 B2
- Genetically encoded fluorescent-iron ferritin nanoparticle probes for detecting an intracellular target by fluorescent and electron microscopy2 Jun 2026US 12,643,929 B2The Salk Institute for Biological Studies
- Method for designing RNA binding protein utilizing PPR motif, and use thereof2 Jun 2026US 12,646,586 B2Kyushu University, National University Corporation
- Method for genetically encoding 2-aminoisobutyric acid and its analogs and applications thereof8 Oct 2026US 2026/0308223 A1Edipro Pharmaceutical Technology Inc.
- Evolved adenine deaminases and rna-guided nuclease fusion proteins with internal insertion sites and methods of use1 Oct 2026US 2026/0297552 A1Life Edit Therapeutics, Inc.
- Recombinant expression vector for production of virus-like particle-based multivalent norovirus vaccine and manufacturing method therefor24 Sep 2026US 2026/0284173 A1Inthera Inc.
- Methods and compositions for regulating gene expression27 Aug 2026US 2026/0250657 A1The University of Chicago
- Integrase variants for gene insertion in human cell13 Aug 2026US 2026/0234577 A1Applied Stemcell, Inc.
Most cited
By later US patents
- Nucleic acid-guided nucleases247US 9,982,279 B1Inscripta, Inc. · 2018
- Use of cationic lipids to deliver CAS997US 9,737,604 B2President and Fellows of Harvard College · 2017
- Delivery system for functional nucleases96US 9,526,784 B2President and Fellows of Harvard College · 2016
- Delivery system for functional nucleases79US 10,682,410 B2President and Fellows of Harvard College · 2020
- Delivery of negatively charged proteins using cationic lipids70US 9,999,671 B2President and Fellows of Harvard College · 2018